Hankyel Park

Array ( [id] => 6275788 [patent_doc_number] => 20020106643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Method for the identification of a receptor' [patent_app_type] => new [patent_app_number] => 10/052299 [patent_app_country] => US [patent_app_date] => 2002-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3650 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20020106643.pdf [firstpage_image] =>[orig_patent_app_number] => 10052299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1101463 [patent_doc_number] => 06815201 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-09 [patent_title] => 'HIV-1 gp120 V1/V2 domain epitopes capable of generating neutralizing antibodies' [patent_app_type] => B2 [patent_app_number] => 10/038407 [patent_app_country] => US [patent_app_date] => 2002-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 28 [patent_no_of_words] => 12500 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/815/06815201.pdf [firstpage_image] =>[orig_patent_app_number] => 10038407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6467173 [patent_doc_number] => 20020150964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Peptides for the activation of the immune system in humans and animals' [patent_app_type] => new [patent_app_number] => 10/038045 [patent_app_country] => US [patent_app_date] => 2002-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 30073 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20020150964.pdf [firstpage_image] =>[orig_patent_app_number] => 10038045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1209045 [patent_doc_number] => 06713281 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-30 [patent_title] => 'Directed evolution of thermophilic enzymes' [patent_app_type] => B2 [patent_app_number] => 10/039293 [patent_app_country] => US [patent_app_date] => 2001-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6103 [patent_no_of_claims] => 92 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713281.pdf [firstpage_image] =>[orig_patent_app_number] => 10039293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1223566 [patent_doc_number] => 06699698 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-02 [patent_title] => 'Method and sample mount system for the in situ separation and enrichment of substances' [patent_app_type] => B1 [patent_app_number] => 09/913619 [patent_app_country] => US [patent_app_date] => 2001-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 29 [patent_no_of_words] => 12188 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/699/06699698.pdf [firstpage_image] =>[orig_patent_app_number] => 09913619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844313 [patent_doc_number] => 20020132299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Production of proteins by cell culture' [patent_app_type] => new [patent_app_number] => 10/024335 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5022 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132299.pdf [firstpage_image] =>[orig_patent_app_number] => 10024335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7677749 [patent_doc_number] => 20040152077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'EXONUCLEASE-MEDIATED NUCLEIC ACID REASSEMBLY IN DIRECTED EVOLUTION' [patent_app_type] => new [patent_app_number] => 10/029221 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 68951 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152077.pdf [firstpage_image] =>[orig_patent_app_number] => 10029221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1104648 [patent_doc_number] => 06812026 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-02 [patent_title] => 'Antibodies directed against binding-associated epitopes' [patent_app_type] => B2 [patent_app_number] => 10/026421 [patent_app_country] => US [patent_app_date] => 2001-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 19 [patent_no_of_words] => 5569 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/812/06812026.pdf [firstpage_image] =>[orig_patent_app_number] => 10026421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1231058 [patent_doc_number] => 06692931 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-17 [patent_title] => 'Recombinant glycoproteins, method for the production thereof, medicaments containing said glycoproteins and use thereof' [patent_app_type] => B1 [patent_app_number] => 09/831868 [patent_app_country] => US [patent_app_date] => 2001-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6898 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 298 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/692/06692931.pdf [firstpage_image] =>[orig_patent_app_number] => 09831868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1207239 [patent_doc_number] => 06712612 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Safe and stable retroviral helper cell line and related compositions and methods' [patent_app_type] => B1 [patent_app_number] => 10/020669 [patent_app_country] => US [patent_app_date] => 2001-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 7687 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/712/06712612.pdf [firstpage_image] =>[orig_patent_app_number] => 10020669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1133726 [patent_doc_number] => 06783981 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-31 [patent_title] => 'Anti-viral vectors' [patent_app_type] => B1 [patent_app_number] => 09/936572 [patent_app_country] => US [patent_app_date] => 2001-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15750 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/783/06783981.pdf [firstpage_image] =>[orig_patent_app_number] => 09936572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6648909 [patent_doc_number] => 20030007983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Two-hybrid assay that detects HIV-1 reverse transcriptase dimerization' [patent_app_type] => new [patent_app_number] => 10/006626 [patent_app_country] => US [patent_app_date] => 2001-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 33449 [patent_no_of_claims] => 108 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0007/20030007983.pdf [firstpage_image] =>[orig_patent_app_number] => 10006626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1231189 [patent_doc_number] => 06692958 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-17 [patent_title] => 'Cord blood-derived activated lymphocytes, preparations containing said lymphocytes as main ingredient and method and kit for producing said preparations' [patent_app_type] => B2 [patent_app_number] => 10/003539 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5712 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/692/06692958.pdf [firstpage_image] =>[orig_patent_app_number] => 10003539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1248015 [patent_doc_number] => 06673574 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-06 [patent_title] => 'Oral delivery of peptides using enzyme-cleavable membrane translocators' [patent_app_type] => B2 [patent_app_number] => 09/997465 [patent_app_country] => US [patent_app_date] => 2001-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11804 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673574.pdf [firstpage_image] =>[orig_patent_app_number] => 09997465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6377163 [patent_doc_number] => 20020119445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Novel recombinant tryptophan mutants of influenza' [patent_app_type] => new [patent_app_number] => 10/001845 [patent_app_country] => US [patent_app_date] => 2001-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11752 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119445.pdf [firstpage_image] =>[orig_patent_app_number] => 10001845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1261113 [patent_doc_number] => 06664063 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-16 [patent_title] => 'Methods for separating,fractionating and analyzing gene of virus existing in hydrosphere' [patent_app_type] => B1 [patent_app_number] => 09/979503 [patent_app_country] => US [patent_app_date] => 2001-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2721 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664063.pdf [firstpage_image] =>[orig_patent_app_number] => 09979503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1133314 [patent_doc_number] => 06783939 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-31 [patent_title] => 'Alphavirus vectors and virosomes with modified HIV genes for use in vaccines' [patent_app_type] => B2 [patent_app_number] => 09/991258 [patent_app_country] => US [patent_app_date] => 2001-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 34548 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/783/06783939.pdf [firstpage_image] =>[orig_patent_app_number] => 09991258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6258721 [patent_doc_number] => 20020187153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells' [patent_app_type] => new [patent_app_number] => 09/986119 [patent_app_country] => US [patent_app_date] => 2001-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12783 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187153.pdf [firstpage_image] =>[orig_patent_app_number] => 09986119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6619134 [patent_doc_number] => 20020086034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Compositions and methods for treating viral infections' [patent_app_type] => new [patent_app_number] => 09/985581 [patent_app_country] => US [patent_app_date] => 2001-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26562 [patent_no_of_claims] => 158 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086034.pdf [firstpage_image] =>[orig_patent_app_number] => 09985581 [rel_patent_id] =>[rel_patent_doc_number] =>)